US · Healthcare

Bicycle Therapeutics Ltd (BCYC)

Biotechnology

Bicycle Therapeutics Ltd (BCYC) is listed on US in the Healthcare sector. Industry: Biotechnology. As of 2026-05-23, reported P/E ratio is 25.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.

Download on the App Store Get it on Google Play

Key metrics for BCYC

P/E ratio

25.00

Bicycle Therapeutics Ltd (BCYC) — FAQ

What is BCYC's P/E ratio?

The price-to-earnings (P/E) ratio for Bicycle Therapeutics Ltd (BCYC) is 25.00 (data as of 2026-05-23).

Does Bicycle Therapeutics Ltd pay a dividend?

Dividend yield is not available in the current snapshot for Bicycle Therapeutics Ltd (BCYC). Check the MyAverix Finance app for the latest dividend data.

What sector is Bicycle Therapeutics Ltd in?

Bicycle Therapeutics Ltd (BCYC) is classified in the Healthcare sector (Biotechnology industry).

What exchange is BCYC listed on?

BCYC is listed on US.

Full report in the app

Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.

Related Healthcare companies

Abbott Laboratories (ABT) AbbVie Inc. CDR (ABBV) Agilent Technologies Inc. (A1GI34) Aimed Bio (0009K0) Alnylam Pharmaceuticals, Inc. (A1LN34) Alvotech (ALVO) Amgen Inc (AMGN34) argenx SE (A1RG34)